Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP+-elicited apoptosis

Neuroscience Research

Volumn 63, Issue 1, 2009, Pages 52-58

  Cheng, Yue Fa ^a   Zhu, Guo Qi ^b   Wang, Mei ^b   Cheng, Hui ^b   Zhou, An ^b   Wang, Ning ^b   Fang, Nianbai ^c   Wang, Xun Cui ^b   Xiao, Xiao Qiu ^d   Chen, Zhi Wu ^a   Li, Qing Lin ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^c HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^d Laboratory of Metabolic Medicine   (Singapore)

Author keywords

Apoptosis; Parkinson's disease; Puerarin; Ubiquitin proteasome system

Indexed keywords

1 METHYL 4 PHENYL 1, 2, 3, 6 TETRAHYDROPYRIDINE; CASPASE 3; CELL PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEINASE; PUERARIN; PYRIDINE DERIVATIVE; UBIQUITIN CONJUGATED PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL;

1-METHYL-4-PHENYLPYRIDINIUM; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CELL LINE, TUMOR; HERBICIDES; HUMANS; ISOFLAVONES; MITOCHONDRIA; MOLECULAR STRUCTURE; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UBIQUITINATION; VASODILATOR AGENTS;

EID: 57649142972     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.10.009     Document Type: Article

References (22)

1. Clarke C.E. Parkinson's disease. BMJ 335 (2007) 441-445
2. Collier T.J., Steece-Collier K., McGuire S., and Sortwell C.E. Cellular models to study dopaminergic injury responses. Ann. N. Y. Acad. Sci. 991 (2003) 140-151
3. Gómez-Santos C., Ferrer I., Santidrián A.F., Barrachina M., Gil J., and Ambrosio S. Dopamine induces autophagic cell death and α-synuclein increase in human neuroblastoma SH-SY5Y cells. J. Neurosci. Res. 73 (2003) 341-350
4. Guerra M.C., Speroni E., Broccoli M., Cangini M., Pasini P., Minghetti A., Crespi-Perellino N., Mirasoli M., Cantelli-Forti G., and Paolini M. Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin: antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci. 67 (2000) 2997-3006
5. Han R.M., Tian Y.X., Becker E.M., Andersen M.L., Zhang J.P., and Skibsted L.H. Puerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with β-carotene. J. Agric. Food Chem. 55 (2007) 2384-2391
6. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Merle R., Evan G.I., Agid Y., and Hirsch E.C. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. PNAS 97 (2000) 2875-2880
7. + on SH-SY5Y cells by decreasing extracellular glutamate level. J. Neurochem. 94 (2005) 1570-1579
8. ++-induced neurotoxicity in PC12 cells mediated by inhibiting mitochondrial dysfunction and caspase-3-like activation. Neurosci. Res. 53 (2005) 183-188
9. Jiang Y., Pei L., Li S., Wang M., and Liu F. Extracellular dopamine induces the oxidative toxicity of SH-SY5Y cells. Synapse 62 (2008) 797-803
10. Lim K.L. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies. Expert. Rev. Proteomics. 4 (2007) 769-781
11. Periquet M., Fulga T., Myllykangas L., Schlossmacher M.G., and Feany M.B. Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. J. Neurosci. 27 (2007) 3338-3346
12. Robert L.N., and Christopher E.E. Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 348 (2003) 1356-1364
13. Sawada H., Kohno R., Kihara T., Izumi Y., Sakka N., Ibi M., Nakanishi M., Nakamizo T., Yamakawa K., Shibasaki H., Yamamoto N., Akaike A., Inden M., Kitamura Y., Taniguchi T., and Shimohama S. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions. J. Biol. Chem. 279 (2004) 10710-10719
14. Sidhu A., Wersinger C., Moussa C.H., and Vernier P. The role of alpha-synuclein in both neuroprotection and neurodegeneration. Ann. N. Y. Acad. Sci. 1035 (2004) 250-270
15. Snyder H., Mensah K., Theisler C., Lee J., Matouschek A., and Wolozin B. Aggregatedand monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function. J. Biol. Chem. 278 (2003) 11753-11759
16. Trojanowski J.Q., and Lee V.M.Y. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch. Neurol. 55 (1998) 151-152
17. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F.F., Yantiri F., Yang L., Beal M.F., and Andersen J.K. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21 (2001) 9519-9528
18. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., and Rubinsztein D.C. Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278 (2003) 25009-25013
19. Yang W., and Tiffany-Castiglioni E. Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: involvement of p53 and mitochondria. J. Toxicol. Environ. Health 71 (2008) 289-299
20. Zhang S.Y., Chen S.L., Shen Y.J., Yang D.J., Liu X.J., Sun-chi A.C., and Xu H.X. Puerarin induces angiogenesis in myocardium of rat with myocardial infarction. Biol. Pharm. Bull. 29 (2006) 945-950
21. Zhang S., Zhou F., Ding J.H., Zhou X.Q., Sun X.L., and Hu G. ATP-sensitive potassium channel opener iptakalim protects against MPP-induced astrocytic apoptosis via mitochondria and mitogen-activated protein kinase signal pathways. J. Neurochem. 103 (2007) 569-579
22. Zhu J.H., Horbinski C., Guo F.L., Watkins S., Uchiyama Y., and Chu C.T. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am. J. Pathol. 170 (2007) 75-86